MARKET

COO

COO

Cooper
NYSE

Real-time Quotes | Nasdaq Last Sale

386.13
-6.00
-1.53%
After Hours: 386.13 0 0.00% 16:24 02/26 EST
OPEN
393.89
PREV CLOSE
392.13
HIGH
393.89
LOW
385.71
VOLUME
297.21K
TURNOVER
--
52 WEEK HIGH
396.86
52 WEEK LOW
236.68
MARKET CAP
18.98B
P/E (TTM)
80.32
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Global Trocars Industry 2019 | Industry Analysis, Top Players, Revenue and Market Share Report
Feb 26, 2021 (Market Insight Reports) -- The latest report on Trocars Market by Infinium Global Research gives complete coverage of the trocars market by...
Market Insight Reports · 1d ago
Cooper Cos. stock falls Friday, underperforms market
Shares of Cooper Cos. slid 1.53% to $386.13 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...
marketwatch.com · 1d ago
IVF Devices and Consumables Market 2021 Global Industry Analysis, Opportunities, Size, Trends, Growth and Forecast 2027
Heraldkeepers · 1d ago
Hyaluronidase Market Size, Share, Growth, Research and Forecast 2020-2026
Feb 26, 2021 (Market Insight Reports) -- The global hyaluronidase market is projected to exhibit a significant growth, at a CAGR of around 7.5%, during the...
Market Insight Reports · 2d ago
What's in Store for Fulgent Genetics (FLGT) in Q4 Earnings?
Zacks.com · 2d ago
Global Fetal and Neonatal Monitoring Devices Market
Feb 25, 2021 (Heraldkeepers) -- COMTEX_381725320/2582/2021-02-25T11:46:18 Is there a problem with this press release? Contact the source provider Comtex at...
Heraldkeepers · 2d ago
Trocars Market Global Forecast to 2023 by Product Type, Tip, Applications, End-Use Industry, Trends, Size, Share, Technology, Major Key Players
Japan, Japan, Thu, 25 Feb 2021 10:15:47 / Comserve Inc. / -- The key players in the trocars market include Medtronic (Ireland), Ethicon (US), B. Braun...
Comserve · 2d ago
What's in Store for Fulgent Genetics (FLGT) in Q4 Earnings?
Zacks.com · 2d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of COO. Analyze the recent business situations of Cooper through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average COO stock price target is 382.75 with a high estimate of 445.00 and a low estimate of 300.00.
EPS
Institutional Holdings
Institutions: 809
Institutional Holdings: 52.08M
% Owned: 105.98%
Shares Outstanding: 49.14M
TypeInstitutionsShares
Increased
169
1.42M
New
105
143.17K
Decreased
183
1.94M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.63%
Key Executives
Non-Executive Chairman/Independent Director
A. Thomas Bender
President/Chief Executive Officer/Director
Albert White
Non-Executive Vice Chairman/Lead Director/Independent Director
Allan Rubenstein
Chief Financial Officer/Executive Vice President/Treasurer
Brian Andrews
Corporate Executive
Holly Sheffield
Chief Operating Officer/Executive Vice President
Daniel McBride
Senior Vice President - Finance/Chief Accounting Officer
Agostino Ricupati
Vice President/General Counsel/Secretary
Mark Drury
Director
Robert Weiss
Independent Director
Colleen Jay
Vice President/IR Contact Officer
Kim Duncan
Independent Director
William Kozy
Independent Director
Jody Lindell
Independent Director
Teresa Madden
Independent Director
Gary Petersmeyer
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
01/07/2021
Dividend USD 0.03
01/21/2021
07/09/2020
Dividend USD 0.03
07/22/2020
01/07/2020
Dividend USD 0.03
01/22/2020
07/10/2019
Dividend USD 0.03
07/22/2019
01/07/2019
Dividend USD 0.03
01/18/2019
07/12/2018
Dividend USD 0.03
07/20/2018
12/12/2017
Dividend USD 0.03
01/22/2018
07/07/2017
Dividend USD 0.03
07/19/2017
01/06/2017
Dividend USD 0.03
01/19/2017
07/08/2016
Dividend USD 0.03
07/20/2016
01/08/2016
Dividend USD 0.03
01/20/2016
07/10/2015
Dividend USD 0.03
07/22/2015
01/09/2015
Dividend USD 0.03
01/21/2015
07/10/2014
Dividend USD 0.03
07/22/2014
01/09/2014
Dividend USD 0.03
01/22/2014
07/12/2013
Dividend USD 0.03
07/22/2013
About COO
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses. CooperVision services three primary regions: the Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific. CooperVision offers spherical, aspherical, toric, multifocal and toric multifocal lens products in various modalities. CooperVision's products are primarily manufactured at its facilities located in the United Kingdom, Puerto Rico, Hungary, Costa Rica and New York. CooperSurgical offers an array of products and services focused on advancing the health of families through a portfolio of products and services focusing on women's health, fertility and diagnostics.

Webull offers kinds of Cooper Companies Inc stock information, including NYSE:COO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading COO stock methods without spending real money on the virtual paper trading platform.